Traditional Chinese medicine needs to prove its worth through rigorous clinical trials, according to the head of one of China’s largest herbal remedy companies, as a contentious new law to boost the $40bn sector comes into effect.
Traditional Chinese medicine is estimated by analysts to account for a third of sales in China’s $117bn pharmaceutical market, the world’s second largest.
But most of those sales are of relatively cheap over-the-counter drugs, with many Chinese hospital doctors reluctant to prescribe TCM remedies because of the lack of evidence for their effectiveness.
您已閱讀18%（583字），剩餘82%（2587字）包含更多重要資訊，訂閱以繼續探索完整內容，並享受更多專屬服務。